Since it is well known that in IBD TNF-α and TGF-β1 are the master regulators of inflammation [57] and fibrosis [58], respectively, we exposed PDOs to treatments with each cytokine alone or both of them in order to reproduce at its best an inflammatory-driven fibrosis. This evidence concerns the gene TGFB1 and inflammatory bowel disease.